And this is consistent with previous reports that norfloxacin could enhance a regulatory T cell-mediated inflammatory control in cirrhosis by maintaining low IL-2 and IFN-γ levels and stimulating IL-10 production (13, 14). Here, IFNG is linked to Cirrhosis.